Regentis Biomaterials (RGNT) Stock Price & Financial Analysis
Regentis Biomaterials Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Regentis Biomaterials
What is the current stock price for RGNT?
As of the latest trading session, RGNT stock trades at $3.11. The 52-week range is $2.80–$8.35, with a day range of $3.04–$3.17.
What is the P/E ratio for RGNT?
Regentis Biomaterials's trailing P/E ratio is 3.1, meaning investors pay $3.1 for every $1 of annual earnings. Regentis Biomaterials operates in the Healthcare sector.
Does RGNT pay dividends?
Regentis Biomaterials does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RGNT?
Analyst ratings and recommendations for RGNT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RGNT?
Regentis Biomaterials's market capitalization is $15.3M, classifying it as a micro-cap company. Regentis Biomaterials operates in the Healthcare sector within the Medical Devices industry.